Drug intelligence / Profile preview

diphenhydramine + hydrocortisone + nystatin + tetracycline

Development stage
Unknown
Lead developer
Compounding pharmacies
Modality
Small Molecules
Administration
Topical, Oral
01

Overview

This is a compounded multi-ingredient oral rinse formulation containing **diphenhydramine**, **hydrocortisone**, **nystatin**, and **tetracycline**. Often categorized as a variant of 'Magic Mouthwash,' this combination is primarily used for the prophylaxis and treatment of stomatitis (oral mucositis), particularly in patients undergoing cancer therapies such as everolimus. The formulation works through a multi-mechanistic approach to manage the complex environment of the oral cavity during treatment: diphenhydramine acts as an antihistamine with local anesthetic properties to provide pain relief; hydrocortisone is a corticosteroid that mitigates local inflammation; nystatin is an antifungal agent that binds to ergosterol in fungal membranes to prevent oral candidiasis (thrush); and tetracycline is a broad-spectrum antibiotic that inhibits bacterial protein synthesis via the 30S ribosomal subunit to prevent secondary infections. It is typically administered using a 'swish and expectorate' method to ensure topical coverage of the oral mucosa.

Brand names
FIRST Duke's MouthwashFIRST Mary's Mouthwash
Other names
Magic MouthwashMiracle MouthwashMary's Magic MouthwashMary's Miracle Mouthwash
02

Targets

NaV (Voltage-gated sodium channels)mAChR (Muscarinic acetylcholine receptors)HRH1 (Histamine H1 Receptor)Bacterial RibosomeGR (Glucocorticoid receptor)Ergosterol

Beyond the preview

Go deeper on diphenhydramine + hydrocortisone + nystatin + tetracycline.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on diphenhydramine + hydrocortisone + nystatin + tetracycline.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call